Nuzenio

Ironwood Advances Apraglutide

Ironwood Advances Apraglutide news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Ironwood Pharmaceuticals Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:36:43 GMTIRWD: LINZESS sales surged and guidance was raised as apraglutide advanced in phase III trials - TradingViewTradingView · Thu, 06 Aug 2026 14:04:41 GMTIRWD: Q2 2026 net sales surged 44% year-over-year, prompting raised full-year guidance - TradingViewTradingView · Thu, 06 Aug 2026 12:31:44 GMTIRWD: Raised 2026 guidance after robust Q2 LINZESS sales, margin gains, and debt repayment - TradingViewTradingView · Thu, 06 Aug 2026 12:28:28 GMTIronwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - Business WireBusiness Wire · Thu, 06 Aug 2026 11:05:00 GMTPress Release: Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - MoomooMoomoo · Thu, 06 Aug 2026 11:05:00 GMTIRWD Rises As Ironwood Advances Apraglutide And Shifts R&D Leadership - StocksToTradeStocksToTrade · Sat, 01 Aug 2026 07:00:00 GMTIronwood Pharmaceuticals to host Q2 2026 investor update call - scanx.tradescanx.trade · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 00:36:43 GMTIronwood Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
Thu, 06 Aug 2026 14:04:41 GMTIRWD: LINZESS sales surged and guidance was raised as apraglutide advanced in phase III trials - TradingView
Thu, 06 Aug 2026 12:31:44 GMTIRWD: Q2 2026 net sales surged 44% year-over-year, prompting raised full-year guidance - TradingView
Thu, 06 Aug 2026 12:28:28 GMTIRWD: Raised 2026 guidance after robust Q2 LINZESS sales, margin gains, and debt repayment - TradingView
Thu, 06 Aug 2026 11:05:00 GMTIronwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - Business Wire
Thu, 06 Aug 2026 11:05:00 GMTPress Release: Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ironwood Advances Apraglutide.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.